Helicobacter pylori
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
A curved Gram-negative rod that colonizes the stomach lining.
Infections
Chronic gastritis, peptic ulcer disease; a risk factor for gastric cancer and MALT lymphoma.
Signs and symptoms
Upper abdominal pain, bloating, nausea; many infections cause no symptoms.
Antibiotic and antimicrobial resistance
Clarithromycin resistance (from 23S rRNA mutations) is common and reduces cure rates; metronidazole resistance also occurs.
Treatment considerations
Combination regimens such as bismuth quadruple therapy, chosen with local resistance patterns in mind; test of cure is recommended.

Sources
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.